Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0297235 ↗Kurz gefasst
Klinische Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Afsoon Dadvar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Mobilisation
Abstract (Originalsprache)
Objectives
Caffeine’s potential benefits on multiple sclerosis (MS), as well as on the ambulatory performance of non-MS populations, prompted us to evaluate its potential effects on balance, mobility, and health-related quality of life (HR-QoL) of persons with MS (PwMS).
Methods
This single-arm pilot clinical trial consisted of a 2-week placebo run-in and a 12-week caffeine treatment (200 mg/day) stage. The changes in outcome measures during the study period (weeks 0, 2, 4, 8, and 12) were evaluated using the Generalized Estimation Equation (GEE). The outcome measures were the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for self-reported ambulatory disability, Berg Balance Scale (BBS) for static and dynamic balance, Timed Up and Go (TUG) for dynamic balance and functional mobility, Multiple Sclerosis Impact Scale (MSIS-29) for patient’s perspective on MS-related QoL (MS-QoL), and Patients’ Global Impression of Change (PGIC) for subjective assessment of treatment efficacy. GEE was also used to evaluate age and sex effect on the outcome measures over time. (Iranian Registry of Clinical Trials, IRCT2017012332142N1).
Results
Thirty PwMS were included (age: 38.89 ± 9.85, female: 76.7%). Daily caffeine consumption significantly improved the objective measures of balance and functional mobility (BBS; P-value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran.
- Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Headache Department, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Melika Jameie, Mohammadamin Parsaei, Hamed Amirifard
Zitieren
APA
Dadvar, A., Jameie, M., Azizmohammad Looha, M., Parsaei, M., Zeynali Bujani, M., Amanollahi, M., Babaei, M., Khosravi, A., & Amirifard, H. (2024). Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0297235
Vancouver
Dadvar A, Jameie M, Azizmohammad Looha M, Parsaei M, Zeynali Bujani M, Amanollahi M, et al. Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0297235
BibTeX
@article{Dadvar2024,
author = {Dadvar, Afsoon and Jameie, Melika and Azizmohammad Looha, Mehdi and Parsaei, Mohammadamin and Zeynali Bujani, Meysam and Amanollahi, Mobina and Babaei, Mahsa and Khosravi, Alireza and Amirifard, Hamed},
title = {Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0297235}
}
EUVIMED